These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 3089256)

  • 21. Long-term efficacy and toxicity of high-dose amiodarone therapy for ventricular tachycardia or ventricular fibrillation.
    Morady F; Sauve MJ; Malone P; Shen EN; Schwartz AB; Bhandari A; Keung E; Sung RJ; Scheinman MM
    Am J Cardiol; 1983 Nov; 52(8):975-9. PubMed ID: 6637851
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Amiodarone for control of sustained ventricular tachyarrhythmia: clinical and electrophysiologic effects in 51 patients.
    Waxman HL; Groh WC; Marchlinski FE; Buxton AE; Sadowski LM; Horowitz LN; Josephson ME; Kastor JA
    Am J Cardiol; 1982 Nov; 50(5):1066-74. PubMed ID: 6291368
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Amiodarone in the management of patients with ventricular tachycardia and ventricular fibrillation.
    Morady F; Scheinman MM; Hess DS
    Pacing Clin Electrophysiol; 1983 May; 6(3 Pt 1):609-15. PubMed ID: 6191299
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [The use of amiodarone and its nursing management in the treatment of supraventricular tachyarrhythmia in an intensive care unit].
    Pavez L; Obregón A; Hermosilla N; Gutiérrez S; Rauld AM; Guerra LA; Bartholomeus N; González A
    Enfermeria; 1984; 18(79):36-8. PubMed ID: 6568172
    [No Abstract]   [Full Text] [Related]  

  • 25. Clinical efficacy of amiodarone as an antiarrhythmic agent.
    Rosenbaum MB; Chiale PA; Halpern MS; Nau GJ; Przybylski J; Levi RJ; Lázzari JO; Elizari MV
    Am J Cardiol; 1976 Dec; 38(7):934-44. PubMed ID: 793369
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cardiac arrest and sudden death in patients treated with amiodarone for sustained ventricular tachycardia or ventricular fibrillation: risk stratification based on clinical variables.
    DiCarlo LA; Morady F; Sauve MJ; Malone P; Davis JC; Evans-Bell T; Winston SA; Scheinman MM
    Am J Cardiol; 1985 Feb; 55(4):372-4. PubMed ID: 3969871
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Treatment of ventricular tachycardia in infancy and childhood with amiodarone].
    Batisse A; Sardet A; Fermont L; Kachaner J
    Arch Mal Coeur Vaiss; 1982 Aug; 75(8):829-35. PubMed ID: 6814383
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Amiodarone: clinical efficacy and toxicity in 96 patients with recurrent, drug-refractory arrhythmias.
    Fogoros RN; Anderson KP; Winkle RA; Swerdlow CD; Mason JW
    Circulation; 1983 Jul; 68(1):88-94. PubMed ID: 6851057
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Amiodarone in antiarrhythmic therapy].
    Petersen A; Andersen ED; Sørensen SS; Sander E
    Ugeskr Laeger; 1984 Jul; 146(31):2311-5. PubMed ID: 6515829
    [No Abstract]   [Full Text] [Related]  

  • 30. [Intravenous amiodarone in the therapy of supraventricular tachyarrhythmia].
    Sparvieri F; Mariotti W; Mariani A; Pierantozzi A
    Minerva Cardioangiol; 1985 Oct; 33(10):623-8. PubMed ID: 4080167
    [No Abstract]   [Full Text] [Related]  

  • 31. Usefulness of electrophysiologic testing in evaluation of amiodarone therapy for sustained ventricular tachyarrhythmias associated with coronary heart disease.
    Horowitz LN; Greenspan AM; Spielman SR; Webb CR; Morganroth J; Rotmensch H; Sokoloff NM; Rae AP; Segal BL; Kay HR
    Am J Cardiol; 1985 Feb; 55(4):367-71. PubMed ID: 3969870
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Should oral amiodarone be used for sustained ventricular tachycardia in patients requiring open-heart surgery?
    MacKinnon G; Landymore R; Marble A
    Can J Surg; 1983 Jul; 26(4):355-7. PubMed ID: 6861030
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Amiodarone--an investigative drug in the coronary care unit.
    Valladares BK; Lemberg L
    Heart Lung; 1983 May; 12(3):325-8. PubMed ID: 6551384
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Amiodarone and sustained ventricular arrhythmias: statistical evidence of drug effectiveness.
    Flaker GC; Alpert MA; Webel RR; Ruder MA; Sanfelippo JF; Tsutakawa RK
    Am Heart J; 1985 Aug; 110(2):371-6. PubMed ID: 4025112
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical use of amiodarone.
    Dunn M
    Heart Lung; 1985 Jul; 14(4):407-11. PubMed ID: 3891691
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antiarrhythmic efficacy and electrophysiologic actions of amiodarone in patients with life-threatening ventricular arrhythmias: potent suppression of spontaneously occurring tachyarrhythmias versus inconsistent abolition of induced ventricular tachycardia.
    Nademanee K; Hendrickson J; Kannan R; Singh BN
    Am Heart J; 1982 Jun; 103(6):950-9. PubMed ID: 7081035
    [No Abstract]   [Full Text] [Related]  

  • 37. ["T'orsade de pointe" and amiodarone (author's transl)].
    Veglia L; Scandiffio T; Guerricchio G
    G Ital Cardiol; 1978; 8(9):1025-9. PubMed ID: 710760
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Indications for the use of amiodarone: a personal perspective.
    Scheinman MM
    Clin Cardiol; 1987 Jul; 10(7 Suppl 1):I1-5. PubMed ID: 3078153
    [No Abstract]   [Full Text] [Related]  

  • 39. Clinical efficacy of intravenous amiodarone in the short term treatment of recurrent sustained ventricular tachycardia and ventricular fibrillation.
    Schützenberger W; Leisch F; Kerschner K; Harringer W; Herbinger W
    Br Heart J; 1989 Nov; 62(5):367-71. PubMed ID: 2590589
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Long-term results of amiodarone therapy in patients with recurrent sustained ventricular tachycardia or ventricular fibrillation.
    Herre JM; Sauve MJ; Malone P; Griffin JC; Helmy I; Langberg JJ; Goldberg H; Scheinman MM
    J Am Coll Cardiol; 1989 Feb; 13(2):442-9. PubMed ID: 2913120
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.